Baixar PDF
Artigo anterior
Voltar à página
Artigo seguinte
If you have problems to see the content please click here
Outros usuários também visualizaram estes artigos
A PHASE 1B/2 STUDY EVALUATING THE SAFETY AND EFFICACY OF NANATINOSTAT PLUS VALGANCICLOVIR FOR TREATMENT OF RELAPSED/REFRACTORY EPSTEIN-BARR VIRUS-POSITIVE NODAL PERIPHERAL T-CELL LYMPHOMA
J Pereira; P Scheinberg; M Capra; P Porcu; S Spruill; D Strickland; B Haverkos;
Hematol Transfus Cell Ther. 2023;45 Supl 4:S344-5
A GLOBAL PHASE 2 TRIAL OF NANATINOSTAT AND VALGANCICLOVIR IN PATIENTS WITH RELAPSED/REFRACTORY EBV-POSITIVE PERIPHERAL T-CELL LYMPHOMAS (NAVAL-1 STAGE 1-2)
M Lacerda; R Nair; H Chang; N Goldschmidt; B Haverkos; H Hua; L Zinzani; D Strickland; E González;
Hematol Transfus Cell Ther. 2024;46 Supl 4:S258-9
NANATINOSTAT WITH OR WITHOUT VALGANCICLOVIR IN PATIENTS WITH RELAPSED/REFRACTORY EBV-POSITIVE PERIPHERAL T-CELL LYMPHOMA (NAVAL-1 STAGE 1)
M Lacerda; R Nair; H Chang; N Goldschmidt; B Haverkos; H Hua; L Zinzani; D Strickland; E González;
Hematol Transfus Cell Ther. 2024;46 Supl 4:S258